United States · FDA National Drug Code directory
Pentoxifylline
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2586_7ee0f77c-2c3e-44fe-9acf-a540e98bd641
- Product NDC
- 71335-2586
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Pentoxifylline
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240611
- Source listing expiry
- 20261231
Source-listed ingredients
- PENTOXIFYLLINE — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2586-1) · 71335-2586-1
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2586-2) · 71335-2586-2
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2586-3) · 71335-2586-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →